Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma

被引：14
|
作者：
Kim, Jung Guk [1 ]
机构：
[1] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, 680 Gukchaebosang Ro, Daegu 700842, South Korea
来源：
ENDOCRINOLOGY AND METABOLISM | 2014年 / 29卷 / 03期
关键词：
Thyroid neoplasms; Targeted therapies;
D O I：
10.3803/EnM.2014.29.3.211
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Four proto-oncogenes commonly associated with well-differentiated thyroid carcinoma, rearranged during transfection (RET)/papillary thyroid cancer, BRAF, RAS, and PAX8/peroxisome proliferator activated receptor-., may carry diagnostic and prognostic significance. These oncogenes can be used to improve the diagnosis and management of well-differentiated thyroid carcinoma. Limited therapeutic options are available for patients with metastatic well-differentiated thyroid cancer, necessitating the development of novel therapies. Vascular endothelial growth factor (VEGF)-and RET-directed therapies such as sorafenib, motesanib, and sunitinib have been shown to be the most effective at inducing clinical responses and stabilizing the disease process. Further clinical trials of these therapeutic agents may soon change the management of thyroid cancer.
引用
收藏
页码：211 / 216
页数：6
相关论文
共 50 条
  • [41] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Iain J. Nixon
    Frank L. Palmer
    Monica M. Whitcher
    Ashok R. Shaha
    Jatin P. Shah
    Snehal G. Patel
    Ian Ganly
    Annals of Surgical Oncology, 2011, 18 : 767 - 770
  • [42] Risk factors for well-differentiated thyroid carcinoma in patients with thyroid nodular disease
    Raza, S. Naweed
    Shah, Manish D.
    Palme, Carsten E.
    Hall, Francis T.
    Eski, Spiro
    Freeman, Jeremy L.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (01) : 21 - 26
  • [43] Surgical strategy for thyroid bed recurrence in patients with well-differentiated thyroid carcinoma
    Palme, CE
    Freeman, JL
    JOURNAL OF OTOLARYNGOLOGY, 2005, 34 (01): : 7 - 12
  • [44] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Nixon, Iain J.
    Palmer, Frank L.
    Whitcher, Monica M.
    R. Shaha, Ashok
    Shah, Jatin P.
    Patel, Snehal G.
    Ganly, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 767 - 770
  • [45] The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors
    Cloyd, Jordan M.
    Konda, Bhavana
    Shah, Manisha H.
    Pawlik, Timothy M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (02) : 101 - 108
  • [46] WELL-DIFFERENTIATED CARCINOMA OF BREAST
    TAYLOR, HB
    NORRIS, HJ
    CANCER, 1970, 25 (03) : 687 - &
  • [47] Advances in Molecular Profiling and Their Potential Influence on the Extent of Surgery in Well-Differentiated Thyroid Carcinoma (WDTC)
    Parpounas, Constantinos
    Constantinides, Vasilis
    LIFE-BASEL, 2023, 13 (06):
  • [48] Management of Well-Differentiated Thyroid Cancer
    Liao, Selena
    Shindo, Maisie
    OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2012, 45 (05) : 1163 - +
  • [49] Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review
    Cavalheiro, Beatriz G.
    Shah, Jatin P.
    Randolph, Gregory W.
    Medina, Jesus E.
    Tufano, Ralph P.
    Zafereo, Mark
    Hartl, Dana M.
    Nixon, Iain J. J.
    Guntinas-Lichius, Orlando
    Vander Poorten, Vincent
    Lopez, Fernando
    Khafif, Avi Hefetz
    Owen, Randall P.
    Shaha, Ashok
    Rodrigo, Juan P.
    Rinaldo, Alessandra
    Maekitie, Antti A.
    Silver, Carl E.
    Sanabria, Alvaro
    Kowalski, Luiz P.
    Ferlito, Alfio
    CANCERS, 2023, 15 (03)
  • [50] Prediction of Radioiodine Treatment Results in Patients with Well-Differentiated Thyroid Carcinoma
    Kowalczyk, A.
    Kaminski, G.
    Jurczyk, M.
    Szalus, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S196 - S196
12345